Southeast Detox GA: Award Winning Suboxone Treatment Center in Rome, GA
May 16, 2024 09:00 ET
|
Southeast Detox GA
Rome, GA, May 16, 2024 (GLOBE NEWSWIRE) -- Southeast Detox GA, a leading inpatient alcohol and drug addiction rehab center, is excited to announce that its Rome Georgia in-patient detox facility has...
Several of GI Alliance’s Managed Practices Recognized as Top Gastroenterology Providers Nationwide
May 16, 2024 08:35 ET
|
GI Alliance
Dallas, TX, May 16, 2024 (GLOBE NEWSWIRE) -- GI Alliance (GIA), the leading network of managed gastroenterology practices in the United States, has had many of its managed practices honored with...
Waterless Beauty and Olive Tree People Achieves over 2000% Q1 Growth and 450% Q1 Growth for Oliveda International, Inc.
May 16, 2024 08:33 ET
|
Oliveda International, Inc.
SANTA MONICA, CA, May 16, 2024 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced that the waterless beauty movement and subsidiary, Olive Tree People Inc., are growing...
Cancer Biomarkers Market is Expected to Reach $42.0 billion | MarketsandMarkets™
May 16, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 16, 2024 (GLOBE NEWSWIRE) -- Cancer Biomarkers market in terms of revenue was estimated to be worth $24.5 billion in 2024 and is poised to reach $42.0 billion by 2029, growing at a CAGR...
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
May 15, 2024 12:17 ET
|
Cooper Aerobics
New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
May 15, 2024 09:00 ET
|
Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
Oligonucleotide Synthesis Market is Expected to Reach $19.7 billion | MarketsandMarkets™
May 15, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 15, 2024 (GLOBE NEWSWIRE) -- Oligonucleotide Synthesis market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET
|
Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...